Bright Minds Biosciences Inc. (DRUG) News
Track canonical SquawkNews coverage tagged to DRUG, Bright Minds Biosciences Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 2 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Bright Minds Biosciences to present at upcoming conferences
Bright Minds Biosciences, Inc. says it will present at upcoming conferences. The company focuses on developing highly selective 5-HT2 agonists for drug-resistant epilepsy, Prader-Willi Syndrome, depression and other indi
EQUITY | Sep 04, 2026, 08:37 PM UTC
L
DRUG - Bright Minds Biosciences to Present at Upcoming Conferences
DRUG - Bright Minds Biosciences to Present at Upcoming Conferences
EQUITY | Sep 04, 2026, 08:30 PM UTC